COPD News

Patients with asthma who were hospitalized for COVID-19 had less severe disease and lower mortality rates than patients with no airway disease, according to a study published in The Journal of Allergy or Clinical Immunology: In Practice.

With the current chest imaging technology, patients with suspected lung infections are unable to receive a specific diagnosis unless they undergo an invasive procedure and wait 2 to 3 days for their results, according to a press release.

Patients with asthma, COPD and interstitial lung disease have reduced SARS-CoV-2 vaccine-specific antibody, B-cell and T-cell responses, which signals poorer protection against COVID-19, according to results published in ERJ Open Research.

More than 50% of older adults with COPD and a history of depression screened positive for depression in autumn 2020 of the COVID-19 pandemic, according to results published in International Journal of Chronic Obstructive Pulmonary Disease.

HONOLULU — The implementation of a post-acute exacerbation COPD clinic reduced hospital readmissions, according to a poster presented at the CHEST Annual Meeting.

Fulfilling criteria for suspected bronchiectasis raised the risk for all-cause mortality among adults with a smoking history, even if they had normal lung function, according to results published in Annals of Internal Medicine.

Exposure to intranasal corticosteroids did not have any adverse impact on COVID-19 mortality among a general population or among patients with asthma or COPD, according to a study published in Annals of Allergy, Asthma & Immunology.

With advancements in artificial intelligence and patient-monitoring technology, properly diagnosing individuals who report wheezing, snoring, coughing or crackles is expected to get easier, according to a review published in CHEST.

The crude rate of hospitalizations for COPD in Canada increased by nearly 70% in 2017 compared with 2002, according to results published in CMAJ.

Acetazolamide taken during stays in high-altitude areas decreases the chances for altitude-related adverse health effects among patients with COPD, according to a European Respiratory Society International Congress presentation.